M&A Deal Summary

Zoetis Acquires Bovigen

On March 18, 2008, Zoetis acquired life science company Bovigen

Acquisition Highlights
  • This is Zoetis’ 3rd transaction in the Life Science sector.
  • This is Zoetis’ 2nd transaction in the United States.
  • This is Zoetis’ 1st transaction in Louisiana.

M&A Deal Summary
Date 2008-03-18
Target Bovigen
Sector Life Science
Buyer(s) Zoetis
Deal Type Add-on Acquisition

Target

Bovigen

Harahan, Louisiana, United States
Bovigen, LLC, based in Harahan, Louisiana, is a global genetic technology company that markets and services Catapult Genetic’s products throughout the Americas.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zoetis

Parsippany, New Jersey, United States
Category Company
Founded 1952
Sector Life Science
Employees11,300
Revenue 8.5B USD (2023)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 3 of 13
Sector (Life Science) 3 of 7
Type (Add-on Acquisition) 3 of 12
State (Louisiana) 1 of 1
Country (United States) 2 of 8
Year (2008) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-18 Catapult Genetics Pty.

Albion, Australia

Catapult is a global provider of sheep and cattle DNA testing technologies for meat and carcass quality and production efficiency under the GeneSTAR® Quality Grade, Feed Efficiency, the SureTRAK® system, and the SireTRACETM product brands. In addition to co-founders Gerard Davis and Jay Hetzel, shareholders include AgResearch, CSIRO, Kestrel Capital’s Nanyang Innovation Fund, and Meat & Wool New Zealand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-10 PHARMAQ Holding AS

Overhalla, Norway

PHARMAQ Holding AS is a pharmaceutical company focused on aquaculture. It develops, manufactures and markets vaccines and therapeutic products for the prevention and treatment of diseases in farmed fish.

Buy $765M
Mergr

Product

Company

Legal